Presenting Fate Therapeutics
Today we are presenting Fate Therapeutics (FATE); a clinical-stage company developing programmed cellular immunotherapies for cancer and immune disorders.

Our enthusiasm for this firm is due to its announcement that it signed a global collaboration agreement with the Johnson & Johnson (This content is for paid subscribers.